China PTCA Balloon Catheter Market Investment Report, 2009-2010
  • Nov/2010
  • Hard Copy
  • USD $1,500
  • Pages:55
  • Single User License
    (PDF Unprintable)       
  • USD $1,600
  • Code: ZYM016
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,400
  • Hard Copy + Single User License
  • USD $1,700
      
Recent years have witnessed a sharp increase in the PCI case load and the application of coronary stent in China. During 2000-2009, the CAGR of PCI case load was above 39.6% on average; and the actual consumption of coronary stent system increased by 38.4% yearly from 2002 to 2009. PTCA balloon catheter not only serves as transport system of stent, but also as device placing front pre-expansion or rear expansion of stent. Along with the evolution of PCI and coronary stent industry, China will see a huge demand in the industry of PTCA balloon catheter. In 2002-2009, China’s demand for PTCA balloon catheter kept an average annual growth rate of 38.1%, with the demand in 2009 recording 653,000 sets.

Demand of PTCA Balloon Catheter in China, 2002-2009 (1,000 sets)
2010123003.gif
Source: ResearchInChina

Due to limitations in technology and recognition, China lags behind in the development of PTCA balloon catheter industry although its import substitution ratio of coronary stent reached 78% in 2009. By contrast, China’s home-made degree of PTCA balloon dilatation catheter (excluding the part as stent transport system) was no more than 20% in 2009. Still, the market is dominated by foreign brands like Medtronic, Abbott Vascular, Boston Scientific, Goodman and Cordis.

Yet, Chinese PTCA balloon catheter market has gained widespread attention from investors worldwide since the breakthroughs in key technologies and the ever expanding market demand in China, and Chinese coronary stent manufacturers have increasingly sharpened the edge in the production of PTCA balloon catheter. As of Oct, 2010, well-known coronary stent suppliers at home such as Lepu Medical, Microport and Beijing Fuji Sunshine Technology are basically capable of producing PTCA balloon catheter for their own application, and they plan to further expand their output capacity of PTCA balloon catheter.

This report probes into the PTCA balloon catheter market of China in terms of current development, macro-economic situation, policy environment (including regional preferential policies), medical & health care level and market supply & demand, revealing the potential demand and investment opportunity of Chinese PTCA balloon catheter market.
1. Related Concepts of PTCA Balloon Catheter Industry
1.1 Definition & Classification of PTCA Balloon Catheter
1.2 Definition & Classification of Intervention Medical Device

2. Operating Environment of Chinese PTCA Balloon Catheter Market
2.1 Macro Economy
2.2 Policy Climate
2.3 Medical & Health Care Level
2.4 Status Quo of Chinese Medical Device Industry

3. Overview of Chinese PTCA Balloon Catheter Market
3.1 Status Quo
3.2 Development Bottleneck
3.3 Supply & Demand
3.3.1 Demand
3.3.1 Supply
3.4 Competition Pattern 

4. Investments in Chinese PTCA Balloon Catheter Market
4.1 Favorable Factors
4.1.1 Strong Support by National Industrial Policy
4.1.2 Financial Incentives
4.1.3 Expanding Market Demand
4.1.4 Increasingly Standardized Market
4.2 Unfavorable Factors
4.2.1 Mounting Risk of Price Drop
4.2.2 Shortage of Related Production Materials and Equipments
4.2.3 Foreign Non-Tariff Barriers
4.3 Economic Benefit
4.4 Choice for Plant Locations
4.4.1 Suzhou
4.4.2 Baoding
4.5 Construction of GMP Plant

5. Key Enterprises 
5.1 Lepu Medical
5.1.1 Profile 
5.1.2 Operation
5.1.3 Production
5.1.4 Prospect & Competitiveness
5.2 Microport
5.2.1 Profile
5.2.2 Operation
5.2.3 Production
5.2.4 Prospect
5.3 JW Medical
5.3.1 Profile
5.3.2 Operation
5.3.3 Production
5.4 Dalian Yinyi
5.4.1 Profile
5.4.2 Operation
5.4.3 Production
5.5 Neich Medical (Shenzhen)
5.5.1 Profile
5.5.2 Operation
5.5.3 Production
5.6 Beijing Fuji Sunshine Technology
5.6.1 Profile
5.6.2 Operation
5.6.3 Production
5.7 SCW Medicath Ltd
5.7.1 Profile
5.7.2 Operation
5.7.3 Production
5.8 SynexMed (Shenzhen)
5.8.1 Profile
5.8.2 Production
5.9 TemMed Medical
5.9.1 Profile
5.9. 2 Production
5.10 Changzhou JIUHONG Medical Instrument
5.10.1 Profile
5.10.2 Operation
Major Devices Used for PCI
Classification of Intervention Devices
Accumulated Value & Growth Rate of China’s GDP, 2007-2010 Q3
Laws and Regulations Related to Chinese Medical Device Industry
Industrial Polices Concerning PTCA Balloon Catheter Industry
Medical & Health Care Expenditure of China and Percentage in GDP, 2000-2009
Medical & Health Care Expenditure Make-ups and Changes in Proportions, 2000-2008 
Medical & Health Care Expenses of Urban and Rural Residents in China and Proportion in Their Consumption Expenditure, 2005-2008 
Gross Output Value of China’s Medical Device Industry, 2005-2009
Sales Revenue and Growth Rate of China’s Medical Device Industry, 2005-2009 
Main Financial Indices of China’s Medical Device Industry, 2005-2009
Market Share of China-made Coronary Drug Stent System, 2006-2009
China’s PCI Cases and Growth Rate, 2000-2009
Consumption and Growth Rate of Coronary Stent System in China, 2002-2009 
Volume of China’s Demand for Coronary Balloon Catheter, 2002-2009
High-value Medical Supplies and Additional Directory of PTCA Balloon Catheter Manufacturers in China, 2008
Main Brands and Market Shares of China’s Major Coronary Balloon Stent System by Consumption, 2009
Market Share Comparison between China-made and Imported Coronary Balloon Catheter, 2009
PCI Cases and Demand for PTCA Balloon Dilatation Catheter in China, 2010-2012
Regional Regulations on the Circulation and Application of Intervention Medical Device
Market Price of Main PTCA Balloon Catheter Brand Products in China, 2004 vs. 2008 
Operating Income, Total Profit and Gross Margin of China’s Artificial Limb, Artificial Organ and Intervention Medical Device Manufacturing, 2006-Aug. 2010
Preferential Policies of Major Industrial Parks in Suzhou
Average Annual Wage of Urban Workers in Jiangsu and Minimum Monthly Wage in Suzhou, 2006-Sep. 2010 
Average Annual Wage of Urban Workers in Hebei and Minimum Monthly Wage in Baoding, 2006-Sep. 2010
Cost Estimation of 100,000-level Clean Plant in China 
Equity Structure of Lepu Medical
Operating Income and Net Income of Lepu Medical, 2006- Q1-Q3,2010
Gross Margin of Major Products of Lepu Medical, 2006- H12010
Operating Income and Percentage of Lepu Medical by Product, 2006-2009
Major Product Capacity of Lepu Medical, 2006- H12010
Major Product Output of Lepu Medical, 2006-2009 
Major Product Sales Volume of Lepu Medical, 2006-2009
Unit Price of Major Products of Lepu Medical, 2006-2009
Operating Income Percentage of Lepu Medical by Region, 2009
Technical Parameters of PTCA Balloon Dilatation Catheter of Lepu Medical
Capacity and Output of Lepu Medical Coronary Balloon Catheter, 2006-2010 
R&D Expenditure and Its Proportion in Operating Income of Lepu Medical, 2006-2009
R&D Pattern of Lepu Medical
Projects to be Built with Raised Funds from Public Offerings by Lepu Medical, Oct. 2009
Lepu Medical Products First Having Passed CE Certification on Sep. 13, 2010
R&D Progress of Lepu Medical Products up to June 2010
MicroPort 18 Medical Device Products, as of Mar, 2010
MicroPort Operating Income & Net Income, 2007-H12010
MicroPort Stent Capacity & Output, 20007-2009
Sales Volume and Unit Price of MicroPort’s Major Stent Products, 2007- Q12010 
MicroPort’s Operating Income and Ratio by Product, 2007- H1 2010
MicroPort’s Operating Income by Region, 2007-H12010
Sales Volume of MicroPort’s Drug Stent Delivery System, 2007-Q12010
Specifications of MicroPort’s PTCA Coronary Dilatation Catheters
MicroPort’s Production of PTCA Coronary Dilatation Catheters, 2009-2010
MicroPort R&D Investment and Ratio to Operating Income, 2007-H12010
MicroPort Latest R&D of New Products, as of Sep, 2010
Operating Indices of Shandong JW Medical, 2007-2008
Operating Indices of Liaoning Biomedical Materials R&D Center Co., Ltd., 2008
Operating Indices of Neich Medical Shenzhen Co., Ltd., 2007-2008
Operating Indices of Beijing Fuji Sunshine Technology Co., Ltd., 2008
Operating Indices of SCW Medicath, Ltd., 2007-2008 
Technical Parameters of PTCA Balloon Catheter of SynexMed (Shenzhen) Co, Ltd.
PTCA Balloon Catheter Development Course of TemMed Medical Co., Ltd
Main Financial Indicators of Changzhou JIUHONG Medical Instrument Co., Ltd., 2008 

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

China Orthopedic Instrument Industry Report, 2013-2015

Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the years, with total market size rising from 3.28 b...

China Ophthalmic Hospital Industry Report, 2012-2015

With the growing types of eye diseases and non-basic medical needs, China’s ophthalmic hospital industry has seen rapid development. In 2011, the number of ophthalmic hospitals in China reached 288, w...

China Chinese Patent Medicine Industry Report, 2012-2015

In recent years, China’s Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Ov...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统